Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme
Open Access
- 1 October 2001
- Vol. 56 (10), 779-784
- https://doi.org/10.1136/thorax.56.10.779
Abstract
BACKGROUND Pulmonary rehabilitation programmes improve the health of patients disabled by lung disease but their cost effectiveness is unproved. We undertook a cost/utility analysis in conjunction with a randomised controlled clinical trial of pulmonary rehabilitation versus standard care. METHODS Two hundred patients, mainly with chronic obstructive pulmonary disease, were randomly assigned to either an 18 visit, 6 week rehabilitation programme or standard medical management. The difference between the mean cost of 12 months of care for patients in the rehabilitation and control groups (incremental cost) and the difference between the two groups in quality adjusted life years (QALYs) gained (incremental utility) were determined. The ratio between incremental cost and utility (incremental cost/utility ratio) was calculated. RESULTS Each rehabilitation programme for up to 20 patients cost £12 120. The mean incremental cost of adding rehabilitation to standard care was £ –152 (95% CI –881 to 577) per patient, p=NS. The incremental utility of adding rehabilitation was 0.030 (95% CI 0.002 to 0.058) QALYs per patient, p=0.03. The point estimate of the incremental cost/utility ratio was therefore negative. The bootstrapping technique was used to model the distribution of cost/utility estimates possible from the data. A high likelihood of generating QALYs at negative or relatively low cost was indicated. The probability of the cost per QALY generated being below £0 was 0.64. CONCLUSIONS This outpatient pulmonary rehabilitation programme produces cost per QALY ratios within bounds considered to be cost effective and is likely to result in financial benefits to the health service.Keywords
This publication has 30 references indexed in Scilit:
- A short outpatient pulmonary rehabilitation programme: immediate and longer term effects on exercise performance and quality of lifeRespiratory Medicine, 1998
- Allergic respiratory disease: strategic targets for primary prevention during childhoodThorax, 1997
- The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trialEuropean Respiratory Journal, 1997
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Developing the Health Care MarketThe Economic Journal, 1991
- The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisalJournal of Hypertension, 1991
- The CE PlaneMedical Decision Making, 1990
- A measure of quality of life for clinical trials in chronic lung disease.Thorax, 1987